F5 and Fuchs endothelial corneal dystrophy: We demonstrated a ~ 23-fold increase of F5 gene expression in CE from FECD patients compared to non-FECD controls, which was in line with the loss of methylation in the predicted enhancer/promoter at position chr1:169,554,071 (GRCh37/hg19) in the FECD group.